Main menu

An end-to-end workflow for pharmacogenomic target enrichment, star allele annotation, and *CYP2D6* resolution

LC2025 Pharmacogenetics PO_1245

Haplotype resolved variant calling, including CYP2D6 structural and copy number variations, through scalable Oxford Nanopore sequencing of pharmacogenetic gene panels and the EPI2ME wf-pgx analysis solution

Download the poster to discover:

  • How Oxford Nanopore adaptive sampling and the Twist Alliance Long-Read PGx Panel target and enrich pharmacogenes, allowing for scalable library preparation and streamlined analysis with wf-pgx
  • How The EPI2ME wf-pgx pipeline accurately genotypes CYP2D6 structural variants with Chinook, a targeted assembly method, and resolves SNV ambiguities in other pharmacogenes with PharmCAT

入門

MinION Starter Packを購入 ナノポア製品の販売 シークエンスサービスプロバイダー グローバルディストリビューター

お問い合わせ

Intellectual property Cookie policy Corporate reporting Privacy policy Terms, conditions and policies Accessibility

Oxford Nanoporeについて

Contact us 経営陣 メディアリソース & お問い合わせ先 投資家向け Oxford Nanopore社で働く BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Japanese flag